Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes

Kidney International

Volumn 62, Issue 3, 2002, Pages 822-831

  Asanuma, Katsuhiko ^a   Shirato, Isao ^a   Ishidoh, Kazumi ^a   Kominami, Eiki ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cathepsin L; Cystatin C; Glomerulosclerosis; Matrix metalloproteinase; Progressive renal disease; TIMP 2

Indexed keywords

CATHEPSIN L; CYSTATIN C; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOBLOTTING; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

EID: 0036424140     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00539.x     Document Type: Article

References (54)

1. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 54:687-697, 1998
2. Mundel P, Kriz W: Structure and function of podocytes: An update. Anat Embryol 192:385-397, 1995
3. Kerjaschki D: Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases. Kidney Int 45:300-313, 1994
4. Shirato I, Sakai T, Kimura K, et al: Cystoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis. Am J Pathol 148:1283-1296, 1996
5. Nagata M, Kriz W: Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42:148-160, 1992
6. Whiteside CI, Cameron R, Munk S, et al: Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis. Am J Pathol 142:1641-1653, 1993
7. Coimbra TM, Janssen U, Grone HJ, et al: Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 57:167-182, 2000
8. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342-348, 1997
9. Kihara I, Tsuchida S, Yaoita E, et al: Podocyte detachment and epithelial cell reaction in focal segmental sclerosis with cellular variants. Kidney Int 52(Suppl 63):S171-S176, 1997
10. Hishiki T, Shirato I, Takahashi Y, et al: Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press Res 24:99-104, 2001
11. Reiser J, Pixley FJ, Hug A, et al: Regulation of mouse podocyte process dynamics by protein tyrosine phosphatases. Kidney Int 57:2035-2042, 2000
12. Schiffer M, Bitzer M, Roberts IS, et al: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108:807-816, 2001
13. Johnson RJ, Lovett D, Lehrer RI, et al: Role of oxidants and proteases in glomerular injury. Kidney Int 45:352-359, 1994
14. Nguyen HH, Baricos WH, Shah SV: Degradation of glomerular basement membrane by a neutral metalloprotease(s) present in glomeruli isolated from normal kidney. Biochem Biophys Res Commun 141:898-903, 1986
15. Le Q, Shah S, Nguyen H, et al: A novel metalloproteinase present in freshly isolated rat glomeruli. Am J Physiol 260:F555-F561, 1991
16. Baricos WH, Cortez SL, Le QC, et al: Glomerular basement membrane degradation by endogenous cysteine proteinases in isolated rat glomeruli. Kidney Int 38:395-401, 1990
17. Baricos WH, Shah SV: Proteolytic enzymes as mediators of glomerular injury. Kidney Int 40:161-173, 1991
18. Martin J, Eynstone L, Davies M, et al: Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J Am Soc Nephrol 12:88-96, 2001
19. McMillan JI, Riordan JW, Couser WG, et al: Characterization of glomerular epithelial cell metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Inves 97:1094-1101, 1996
20. Johnson R, Yamabe H, Chen YP, et al: Glomerular epithelial cells secrete a glomerular basement membrane-degrading metalloproteinase. J Am Soc Nephrol 2:1388-1397, 1992
21. Knowlden J, Martin J, Davies M, et al: Metalloproteinase generation by human glomerular epithelial cells. Kidney Int 47:1682-1689, 1995
22. Martin J, Steadman R, Knowlden J, et al: Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro. J Am Soc Nephrol 9:1629-1637, 1998
23. Turk B, Turk D, Turk V: Lysosomal cysteine proteases: More than scavengers. Biochim Biophys Acta 1477:98-111, 2000
24. Ishidoh K, Kominami E: Gene regulation and extracellular functions of procathepsin L. Biol Chem 379:131-135, 1998
25. Kriz W, Hahnel B, Rosener S, et al: Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int 48:1435-1450, 1995
26. Kopp JB, Factor VM, Mozes M, et al: Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74:991-1003, 1996
27. Gesualdo L, Pinzani M, Floriano JJ, et al: Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 65:160-167, 1991
28. Mundel P, Reiser J, Zuniga Mejia Borja A, et al: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236:248-258, 1997
29. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
30. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
31. Ishidoh K, Kominami E: Multi-step processing of procathepsin L in vitro. FEBS Lett 352:281-284, 1994
32. Cancilla B, Davies A, Cauchi JA, et al: Fibroblast growth factor receptors and their ligands in the adult rat kidney. Kidney Int 60:147-155, 2001
33. Fujigaki Y, Watanabe T, Ikegaya N, et al: Immunoelectron microscopic study on type I, II and III TGF-beta receptors on visceral glomerular epithelial cells in relation to glomerular basement membrane alterations in proteinuric rats. Nephrol Dial Transplant 15:191-199, 2000
34. Gesualdo L, Di Paolo S, Milani S, et al: Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J Clin Invest 94:50-58, 1994
35. Shih NY, Li J, Cotran R, et al: CD2AP localizes to the slit diaphragm and binds to nephrin via a novel c-terminal domain. Am J Pathol 159:2303-2308, 2001
36. Kretzler M, Schroppel B, Merkle M, et al: Detection of multiple vascular endothelial growth factor splice isoforms in single glomerular podocytes. Kidney Int 54(Suppl 67):S159-S161, 1998
37. Floege J, Kriz W, Schulze M, et al: Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest 96:2809-2819, 1995
38. Sasaki T, Jyo Y, Tanda N, et al: Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy. Kidney Int 51:301-309, 1997
39. Ishidoh K, Kominami E: Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun 217:624-631, 1995
40. Ishidoh K, Saido TC, Kawashima S, et al: Multiple processing of procathepsin L to cathepsin L in vivo. Biochem Biophys Res Commun 252:202-207, 1998
41. Shi GP, Sukhova GK, Grubb A, et al: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104:1191-1197, 1999
42. Webster KA, Discher DJ, Kaiser S, et al: Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 104:239-252, 1999
43. Parak WJ, Dannohl S, George M, et al: Metabolic activation stimulates acid production in synovial fibroblasts. J Rheumatol 27:2312-2322, 2000
44. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol 267:C195-C203, 1994
45. Jahde E, Volk T, Atema A, et al: pH in human tumor xenografts and transplanted rat tumors: Effect of insulin, inorganic phosphate, and m-iodobenzylguanidine. Cancer Res 52:6209-6215, 1992
46. Bellocq A, Suberville S, Philippe C, et al: Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappa B activation. J Biol Chem 273:5086-5092, 1998
47. Silver IA, Murrills R J, Etherington DJ: Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175:266-276, 1988
48. + and cathepsin L by glomerular epithelial cells. Am J Physiol (Renal Physiol) 282:F26-F33, 2002
49. Border WA, Ruoslahti E: Transforming growth factor-beta in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
50. MacKay K, Striker LJ, Stauffer JW, et al: Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
51. Felbor U, Dreier L, Bryant RA, et al: Secreted cathepsin L generates endstatin from collagen XVIII. EMBO J 19:1187-1194, 2000
52. Panchenko MV, Stetler-Stevenson WG, Trubetskoy OV, et al: Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase. J Biol Chem 271:7113-7119, 1996
53. Silver BJ, Jaffer FE, Abboud HE: Platelet-derived growth factor synthesis in mesangial cells: Induction by multiple peptide mitogens. Proc Natl Acad Sci USA 86:1056-1060, 1989
54. Johnson RJ, Raines EW, Floege J, et al: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992